Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 01:52PM ET
5.17
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-2.30 Insider Own49.91% Shs Outstand2.98M Perf Week12.15%
Market Cap18.20M Forward P/E- EPS next Y-6.82 Insider Trans7.89% Shs Float1.76M Perf Month30.89%
Income-7.12M PEG- EPS next Q-1.85 Inst Own2.31% Short Float6.39% Perf Quarter45.63%
Sales0.00M P/S- EPS this Y-140.44% Inst Trans5.76% Short Ratio0.14 Perf Half Y32.39%
Book/sh1.73 P/B2.99 EPS next Y6.95% ROA-81.33% Short Interest0.11M Perf Year104.75%
Cash/sh2.02 P/C2.56 EPS next 5Y- ROE-102.31% 52W Range1.37 - 8.65 Perf YTD203.94%
Dividend Est.- P/FCF- EPS past 5Y-14.80% ROI-116.98% 52W High-40.23% Beta1.27
Dividend TTM- Quick Ratio6.59 Sales past 5Y0.00% Gross Margin- 52W Low277.51% ATR (14)0.63
Dividend Ex-Date- Current Ratio6.59 EPS Y/Y TTM39.50% Oper. Margin0.00% RSI (14)57.85 Volatility11.22% 17.07%
Employees10 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price18.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q40.25% Payout- Rel Volume0.25 Prev Close5.17
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsAug 09 BMO Avg Volume807.43K Price5.17
SMA203.86% SMA5045.10% SMA20054.83% Trades Volume138,566 Change0.00%
Date Action Analyst Rating Change Price Target Change
TodayInitiated Rodman & Renshaw Buy $50
Jan-28-21Initiated ROTH Capital Buy $49
Oct-08-24 08:30AM
Oct-07-24 08:00AM
Sep-12-24 08:00AM
Sep-04-24 08:00AM
Aug-27-24 04:05PM
08:00AM Loading…
Aug-21-24 08:00AM
Aug-14-24 08:00AM
Aug-12-24 12:24PM
Aug-09-24 02:53PM
08:00AM
08:00AM
Jul-09-24 07:00AM
Jun-25-24 08:00AM
Jun-11-24 07:30AM
Jun-10-24 08:00AM
06:15AM Loading…
Jun-05-24 06:15AM
May-24-24 08:00AM
May-17-24 09:55AM
May-09-24 01:55PM
07:00AM
Apr-18-24 08:00AM
Apr-16-24 08:00AM
Apr-10-24 08:00AM
Apr-04-24 09:55AM
Apr-03-24 12:00PM
Mar-28-24 11:53AM
07:00AM
Mar-05-24 07:00AM
Feb-27-24 07:00AM
Feb-23-24 11:55AM
07:00AM Loading…
Feb-22-24 07:00AM
Feb-20-24 08:00AM
Nov-09-23 08:37AM
07:00AM
Nov-01-23 07:00AM
Oct-10-23 07:00AM
Sep-05-23 07:00AM
Aug-10-23 07:00AM
Aug-08-23 07:00AM
Jul-11-23 07:00AM
Jun-21-23 07:00AM
Jun-14-23 07:00AM
Jun-01-23 07:00AM
May-29-23 09:55AM
May-11-23 07:00AM
Apr-19-23 09:55AM
Mar-28-23 01:40PM
07:00AM
Mar-27-23 05:00PM
Mar-23-23 07:00AM
Mar-07-23 07:00AM
Feb-27-23 07:00AM
Feb-14-23 12:46PM
07:00AM
Feb-05-23 08:38AM
Jan-26-23 07:00AM
Jan-18-23 07:00AM
Dec-12-22 07:00AM
Nov-18-22 01:10PM
09:55AM
Nov-16-22 10:09AM
07:00AM
Nov-10-22 08:00AM
Oct-27-22 08:00AM
Oct-19-22 08:00AM
Oct-12-22 08:00AM
Oct-05-22 08:50AM
08:00AM
Sep-28-22 08:00AM
Aug-28-22 10:49AM
Aug-18-22 09:55AM
Aug-11-22 08:05AM
May-12-22 08:00AM
Mar-24-22 08:00AM
Mar-21-22 03:18PM
Mar-08-22 08:00AM
Feb-15-22 08:05AM
Jan-07-22 07:05AM
Dec-08-21 08:00AM
Nov-12-21 08:00AM
Oct-27-21 08:05AM
Sep-22-21 08:30AM
Sep-16-21 08:00AM
Sep-13-21 08:00AM
Sep-09-21 08:00AM
Aug-12-21 08:00AM
Aug-05-21 08:00AM
Aug-03-21 08:00AM
Jul-12-21 08:00AM
Jun-24-21 08:00AM
Jun-03-21 08:00AM
May-26-21 08:00AM
May-24-21 08:00AM
May-13-21 04:42PM
Mar-30-21 10:13AM
07:30AM
Mar-26-21 06:22AM
Mar-25-21 08:00AM
Mar-02-21 07:30AM
Feb-24-21 07:30AM
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cittadine AndrewChief Operating OfficerJun 20 '24Buy0.7420,50815,254186,132Jun 21 05:16 PM
Cittadine AndrewChief Operating OfficerJun 18 '24Buy0.8612,00010,320165,624Jun 21 05:16 PM
Cittadine AndrewChief Operating OfficerJun 14 '24Buy0.9312,00011,176141,624Jun 17 06:08 PM
Cittadine AndrewChief Operating OfficerJun 13 '24Buy0.9112,00010,920129,624Jun 17 06:08 PM
Cittadine AndrewChief Operating OfficerJun 17 '24Buy0.9012,00010,799153,624Jun 17 06:08 PM
Cittadine AndrewChief Operating OfficerJun 04 '24Buy0.7812,0009,360117,624Jun 05 06:12 PM
Cittadine AndrewChief Operating OfficerJun 03 '24Buy0.7612,0009,120105,624Jun 05 06:12 PM
Cittadine AndrewChief Operating OfficerMay 31 '24Buy0.6412,0007,73293,624May 31 04:56 PM
Cittadine AndrewChief Operating OfficerMay 30 '24Buy0.6412,0007,67681,624May 31 04:56 PM
Cittadine AndrewChief Operating OfficerMay 29 '24Buy0.6412,0007,64369,624May 31 04:56 PM